The estimated Net Worth of Abigail L. Jenkins is at least $8.7 Tausend dollars as of 30 September 2022. Abigail Jenkins owns over 16,129 units of Gamida Cell Ltd stock worth over $8,702 and over the last 2 years Abigail sold GMDA stock worth over $0.
Abigail has made over 1 trades of the Gamida Cell Ltd stock since 2022, according to the Form 4 filled with the SEC. Most recently Abigail bought 16,129 units of GMDA stock worth $25,000 on 30 September 2022.
The largest trade Abigail's ever made was buying 16,129 units of Gamida Cell Ltd stock on 30 September 2022 worth over $25,000. On average, Abigail trades about 4,032 units every 0 days since 2022. As of 30 September 2022 Abigail still owns at least 266,129 units of Gamida Cell Ltd stock.
You can see the complete history of Abigail Jenkins stock trades at the bottom of the page.
Abigail's mailing address filed with the SEC is C/O AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN, NJ, 07059.
Over the last 3 years, insiders at Gamida Cell Ltd have traded over $0 worth of Gamida Cell Ltd stock and bought 85,483 units worth $132,499 . The most active insiders traders include Stephen T Wills, Robert I Blum und Jeremy Blank. On average, Gamida Cell Ltd executives and independent directors trade stock every 0 days with the average trade being worth of $699. The most recent stock trade was executed by Stephen T Wills on 30 September 2022, trading 9,677 units of GMDA stock currently worth $14,999.
gamida cell is a leader in cellular and immune therapeutics, committed to changing the treatment paradigm for patients with cancer and rare genetic diseases. we are building a broad pipeline based on our proprietary nam technology platform. our lead program, nicord, is in phase 3 development for allogeneic bone marrow transplantation and was granted breakthrough therapy designation by the fda.
Gamida Cell Ltd executives and other stock owners filed with the SEC include: